Responses
Inflammation and inflammatory bowel disease
Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses
Compose a Response to This Article
Other responses
No responses have been published for this article.